Chronic obstructive pulmonary disease: the evidence for use of tiotropium

Tiotropium is the first long-acting anticholinergic bronchodilator for the treatment of chronic obstructive pulmonary disease. There is now evidence that it improves key clinical outcomes. Doctors need to decide how this evidence base should influence clinical practice.